Group 1 - The core point of the article is that Tailin Bio has recently obtained four patent certificates through its wholly-owned subsidiaries, indicating a focus on innovation and development in the biotechnology sector [1] - The patents include methods and devices for maintaining temperature, hydrogen peroxide gas concentration, and saturation, as well as a dual-sterilization internal circulation sterile isolator, showcasing the company's technological advancements [1] - For the fiscal year 2024, Tailin Bio's revenue composition is projected to be 90.04% from the pharmaceutical industry and 9.96% from other businesses, highlighting the company's strong reliance on the pharmaceutical sector [1] Group 2 - As of the report, Tailin Bio has a market capitalization of 4 billion yuan, reflecting its position in the market [1]